Yüklüyor…
Inhibition of Androgen Signalling Improves the Outcomes of Therapies for Bladder Cancer: Results from a Systematic Review of Preclinical and Clinical Evidence and Meta-Analysis of Clinical Studies
Bladder cancer (BCa) is an endocrine-related tumour and the activation of androgen signalling pathways may promote bladder tumorigenesis. We summarized the available preclinical and clinical evidence on the implications of the manipulation of androgen signalling pathways on the outcomes of BCa thera...
Asıl Yazarlar: | , , , , , , , , , , , , , , |
---|---|
Materyal Türü: | Online Makale Metin |
Dil: | English |
Baskı/Yayın Bilgisi: |
MDPI
2021
|
Konular: | |
Online Erişim: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923424/ https://www.ncbi.nlm.nih.gov/pubmed/33672461 http://dx.doi.org/10.3390/diagnostics11020351 |